Literature DB >> 20236222

Contributions of poly(ADP-ribose) polymerase-1 and -2 to nuclear translocation of apoptosis-inducing factor and injury from focal cerebral ischemia.

Xiaoling Li1, Judith A Klaus, Jian Zhang, Zhenfeng Xu, Kathleen K Kibler, Shaida A Andrabi, Karthik Rao, Zeng-Jin Yang, Ted M Dawson, Valina L Dawson, Raymond C Koehler.   

Abstract

Excessive oxidative damage to DNA leads to activation of poly(ADP-ribose) polymerase-1 (PARP-1), accumulation of PAR polymers, translocation of apoptosis-inducing factor (AIF) from mitochondria to the nucleus, and cell death. In this study, we compared the effect of gene deletion of PARP-1 and PARP-2, enzymes activated by DNA oxidative damage, in male mice subjected to 2 h of focal cerebral ischemia. Infarct volume at 3 days of reperfusion was markedly decreased to a similar extent in PARP-1- and PARP-2-null mice. The ischemia-induced increase in nuclear AIF accumulation was largely suppressed in both knockout genotypes. The transient increase in PAR during early reperfusion was nearly blocked in PARP-1-null mice, but only moderately decreased at 1-h reperfusion in PARP-2-null mice. Differences in the tissue volume at risk, as assessed by arterial casts and autoradiographic analysis of regional blood flow, did not fully account for the large reductions in AIF translocation and infarct volume in both PARP null mice. Cell death was attenuated in PARP-2-null neurons exposed to a submaximal concentration of 100 microM NMDA for 5 min, but not in those exposed to a near-maximal toxic concentration of 500 microM NMDA. We conclude that PARP-2 contributes substantially to nuclear translocation of AIF and infarct size after transient focal cerebral ischemia in male mice, but that protection is disproportionate to the attenuation of overall PARP activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20236222      PMCID: PMC2860677          DOI: 10.1111/j.1471-4159.2010.06667.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  37 in total

1.  NMDA but not non-NMDA excitotoxicity is mediated by Poly(ADP-ribose) polymerase.

Authors:  A S Mandir; M F Poitras; A R Berliner; W J Herring; D B Guastella; A Feldman; G G Poirier; Z Q Wang; T M Dawson; V L Dawson
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

2.  Characterization of a new double-filament model of focal cerebral ischemia in heme oxygenase-2-deficient mice.

Authors:  Shozo Goto; Kenji Sampei; Nabil J Alkayed; Sylvain Doré; Raymond C Koehler
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-03-27       Impact factor: 3.619

3.  Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1.

Authors:  Valérie Schreiber; Jean-Christophe Amé; Pascal Dollé; Inès Schultz; Bruno Rinaldi; Valérie Fraulob; Josiane Ménissier-de Murcia; Gilbert de Murcia
Journal:  J Biol Chem       Date:  2002-04-10       Impact factor: 5.157

4.  Poly(ADP-ribose) polymerase impairs early and long-term experimental stroke recovery.

Authors:  Shozo Goto; Rong Xue; Nobuo Sugo; Masahiko Sawada; Kathleen K Blizzard; Marc F Poitras; David C Johns; Ted M Dawson; Valina L Dawson; Barbara J Crain; Richard J Traystman; Susumu Mori; Patricia D Hurn
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

5.  Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.

Authors:  G E Abdelkarim; K Gertz; C Harms; J Katchanov; U Dirnagl; C Szabó; M Endres
Journal:  Int J Mol Med       Date:  2001-03       Impact factor: 4.101

6.  Nuclear translocation of apoptosis-inducing factor after focal cerebral ischemia.

Authors:  Nikolaus Plesnila; Changlian Zhu; Carsten Culmsee; Moritz Gröger; Michael A Moskowitz; Klas Blomgren
Journal:  J Cereb Blood Flow Metab       Date:  2004-04       Impact factor: 6.200

7.  Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse.

Authors:  Josiane Ménissier de Murcia; Michelle Ricoul; Laurence Tartier; Claude Niedergang; Aline Huber; Françoise Dantzer; Valérie Schreiber; Jean-Christophe Amé; Andrée Dierich; Marianne LeMeur; Laure Sabatier; Pierre Chambon; Gilbert de Murcia
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

8.  Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor.

Authors:  Seong-Woon Yu; Hongmin Wang; Marc F Poitras; Carmen Coombs; William J Bowers; Howard J Federoff; Guy G Poirier; Ted M Dawson; Valina L Dawson
Journal:  Science       Date:  2002-07-12       Impact factor: 47.728

9.  Functional interplay between Parp-1 and SirT1 in genome integrity and chromatin-based processes.

Authors:  Rosy El Ramy; Najat Magroun; Nadia Messadecq; Laurent R Gauthier; François D Boussin; Ullas Kolthur-Seetharam; Valérie Schreiber; Michael W McBurney; Paolo Sassone-Corsi; Françoise Dantzer
Journal:  Cell Mol Life Sci       Date:  2009-08-12       Impact factor: 9.261

Review 10.  The role of poly(ADP-ribosyl)ation in epigenetic events.

Authors:  Delphine Quénet; Rosy El Ramy; Valérie Schreiber; Françoise Dantzer
Journal:  Int J Biochem Cell Biol       Date:  2008-08-14       Impact factor: 5.085

View more
  22 in total

Review 1.  Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

Authors:  Nathan A Berger; Valerie C Besson; A Hamid Boulares; Alexander Bürkle; Alberto Chiarugi; Robert S Clark; Nicola J Curtin; Salvatore Cuzzocrea; Ted M Dawson; Valina L Dawson; György Haskó; Lucas Liaudet; Flavio Moroni; Pál Pacher; Peter Radermacher; Andrew L Salzman; Solomon H Snyder; Francisco Garcia Soriano; Robert P Strosznajder; Balázs Sümegi; Raymond A Swanson; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2017-03-26       Impact factor: 8.739

Review 2.  Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells.

Authors:  Antoine Monsel; Ying-Gang Zhu; Stephane Gennai; Qi Hao; Jia Liu; Jae W Lee
Journal:  Anesthesiology       Date:  2014-11       Impact factor: 7.892

Review 3.  Poly(ADP-ribose) polymerase-1 in amyloid beta toxicity and Alzheimer's disease.

Authors:  Joanna B Strosznajder; Grzegorz A Czapski; Agata Adamczyk; Robert P Strosznajder
Journal:  Mol Neurobiol       Date:  2012-03-20       Impact factor: 5.590

Review 4.  Poly(ADP-Ribosylation) in Age-Related Neurological Disease.

Authors:  Leeanne McGurk; Olivia M Rifai; Nancy M Bonini
Journal:  Trends Genet       Date:  2019-06-07       Impact factor: 11.639

Review 5.  Neuronal Cell Death.

Authors:  Michael Fricker; Aviva M Tolkovsky; Vilmante Borutaite; Michael Coleman; Guy C Brown
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 6.  Apoptosis-inducing factor: structure, function, and redox regulation.

Authors:  Irina F Sevrioukova
Journal:  Antioxid Redox Signal       Date:  2011-03-10       Impact factor: 8.401

Review 7.  CaMKII in cerebral ischemia.

Authors:  Steven J Coultrap; Rebekah S Vest; Nicole M Ashpole; Andy Hudmon; K Ulrich Bayer
Journal:  Acta Pharmacol Sin       Date:  2011-06-20       Impact factor: 6.150

8.  Role of Bax in death of uninfected retinal cells during murine cytomegalovirus retinitis.

Authors:  Juan Mo; Brendan Marshall; Jason Covar; Nancy Y Zhang; Sylvia B Smith; Sally S Atherton; Ming Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-08       Impact factor: 4.799

9.  Peroxiredoxin 2 battles poly(ADP-ribose) polymerase 1- and p53-dependent prodeath pathways after ischemic injury.

Authors:  Rehana K Leak; Lili Zhang; Yumin Luo; Peiying Li; Haiping Zhao; Xiangrong Liu; Feng Ling; Jianping Jia; Jun Chen; Xunming Ji
Journal:  Stroke       Date:  2013-02-21       Impact factor: 7.914

10.  PARP1-mediated necrosis is dependent on parallel JNK and Ca²⁺/calpain pathways.

Authors:  Diana L Douglas; Christopher P Baines
Journal:  J Cell Sci       Date:  2014-07-22       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.